Shire Pharmaceuticals Group plc, Richwood Pharmaceutical Co. Inc. deal

SHP will acquire Richwood, a developer of drugs for central nervous system disorders, for up to $185.7 million,

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE